Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Gilead Sciences promoted John Milligan to chief executive as John Martin becomes executive chairman. Martin joined the drug maker in 1990 and became CEO in 1996. Milligan joined Gilead at the same time and was named chief operating officer in 2007 and president in 2008.

Actinium Pharmaceuticals hired Rowena Choudrie as senior director, pharma product development;


Actinium Pharmaceuticals hired Kevin Zikaras as senior clinical scientist;

EMD Serono promoted Gary Zieziula to president and managing director, North America;


Tarveda Therapeutics hired Dr. Leila Alland as chief medical officer;

Surface Oncology hired Dr. Vito Palombella as chief scientific officer;

Heron Therapeutics hired Kimberly Manhard as executive vice president of drug development;

Phico Therapeutics hired Dr. Nicki Thompson as chief business officer;

Soricimed Biopharma hired Bob Cory as vice president of business development;

DBV Technologies hired Ed Jordan as senior VP, commercial operations North America;

Pharmaceutical Strategies Group hired Thomas Camp as senior VP of sales for its 340B Solutions group;

Chugai Pharmaceuticals named Toshihiko Komori as VP, general manager of translational clinical research;

ACADIA Pharmaceuticals hired Dr. James Owen as senior VP, clinical development and chief medical officer.